Related Experiment Video
Updated: May 16, 2026

07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Metastatic haematological malignancy presenting as a sellar mass
Maneesh Udiawar1, Christina Bejnariu, Stephen Davies
1Centre for Endocrine and Diabetes Sciences, University Hospital of Wales, Cardiff, UK. man1210@yahoo.com
BMJ Case Reports
|November 24, 2012
Summary
A sellar mass in a multiple myeloma patient was diagnosed as a sellar plasmacytoma. This rare occurrence highlights the importance of considering extramedullary disease in myeloma patients with sellar lesions.
Area of Science:
- Neuro-oncology
- Hematology
- Endocrinology
Background:
- Multiple myeloma is a hematologic malignancy characterized by the proliferation of plasma cells.
- Sellar masses can present with various symptoms, including headaches and visual disturbances.
- Extramedullary disease in multiple myeloma, while uncommon, can involve various organs.
Observation:
- A 60s male with a history of multiple myeloma presented with a sellar mass causing headaches and double vision.
- MRI revealed a large sellar mass with invasion into the sphenoid and cavernous sinuses.
- Biopsy confirmed a sellar plasmacytoma, a rare extramedullary manifestation.
Findings:
- The sellar lesion consisted of mature plasma cells exclusively staining for kappa-light chain immunoglobulins.
- Pituitary function tests revealed hypogonadotrophic hypogonadism.
- The patient was treated with chemotherapy for myeloma and radiotherapy for plasmacytoma.
Implications:
- This case underscores the potential for sellar plasmacytoma as an extramedullary manifestation of multiple myeloma.
- Early diagnosis and appropriate treatment are crucial for managing such rare presentations.
- Further research into the mechanisms and management of extramedullary plasmacytomas is warranted.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...